Sherpa News

Sherpa Clinical Packaging to Convene Expert Panel on Brexit’s Impact on Clinical Trials in the European Union

Panel to Focus on Brexit’s Implications for the US Pharmaceutical Industry

San Diego, Calif. July 26, 2017— The UK’s decision to exit the European Union has far-reaching implications for US pharmaceutical companies trying to break into the EU drug market. The lack of regulatory clarity during this negotiation period between the UK and the EU makes it difficult to plan and execute long-term clinical strategies in the EU. Sherpa Clinical Packaging will be convening a panel of experts to advise on future milestones that pharmaceutical companies should carefully consider as they solidify their plans to bring potential life-saving therapies to the EU clinical research market.

Read More

Sherpa Clinical Packaging Expands Operational Capacity

SAN DIEGO, March 30, 2017 /PRNewswire/ —  Sherpa Clinical Packaging continues to invest in growth and infrastructure with its latest facility addition. The facility expansion will support continued growth in Sherpa’s packaging, labeling, and distribution services, especially as it relates to later stage projects and global studies. The new building will house four packaging suites, a class 100,000 cleanroom, and various temperature-controlled storage areas including expansive 2-8°C and -20°C rooms, and a Controlled Room Temperature warehouse. The new cGMP facility consists of 24,000 ft2 and is adjacent to Sherpa’s existing 38,000 ft2 headquarters.

Read More

Sherpa Clinical Packaging moves blistering capabilities in-house

SAN DIEGO, Sept. 13, 2016 /PRNewswire/ –Sherpa Clinical Packaging, a leading provider of clinical materials management services is now offering in-house blister packaging capabilities available at its facility in San Diego, CA. The new capability will help Sherpa better serve the increasing demands for primary clinical packaging services.

Read More

Sherpa Clinical Packaging announces completion of move to a new GMP clinical Packaging and Distribution facility in San Diego

SAN DIEGO, Feb. 22, 2016 /PRNewswire/ — Sherpa, a clinical packaging company strategically located in the heart of the San Diego biotech community, demonstrates commitment to its clinical trial materials management business by investing in infrastructure. The new state-of-the-art facility is 37,500 ft2 and offers enhanced capabilities and a strict cold chain management infrastructure. The expansion was needed to support the company’s increased demand for Phase 2 and Phase 3 clinical studies and is a result of continued growth serving new and existing clients.

Read More